Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO20880 | Conocybe siliginea | Species | Bolbitiaceae | Eukaryota | UNPD* | |||
NPO10014 | Rubia tinctorum | Species | Rubiaceae | Eukaryota | TCM_Taiwan* | |||
NPO17395 | Asperula odorata | Species | Rubiaceae | Eukaryota | TCM_Taiwan* | |||
NPO26542 | Rubia cordifolia | Species | Rubiaceae | Eukaryota | TCM_Taiwan* | |||
NPO28024 | Rheum palmatum | Species | Polygonaceae | Eukaryota | TCM_Taiwan* | |||
NPO30535 | Morinda umbellata | Species | Rubiaceae | Eukaryota | TCM_Taiwan* | |||
NPO4323 | Morinda citrifolia | Species | Rubiaceae | Eukaryota | TCM_Taiwan* | |||
NPO20822 | Asperula odora | Species | Rubiaceae | Eukaryota | UNPD* | |||
NPO19792 | Populus tomentosa | Species | Salicaceae | Eukaryota | UNPD* | |||
NPO20572 | Vepris louisii | Species | Rutaceae | Eukaryota | UNPD* | |||
NPO20364 | Ophelia bicornis | Species | Opheliidae | Eukaryota | UNPD* | |||
NPO26542 | Rubia cordifolia | Species | Rubiaceae | Eukaryota | TCMSP* | |||
NPO25238 | Rheum coreanum | Species | Polygonaceae | Eukaryota | TM-MC* | |||
NPO20881 | Rheum officinale | Species | Polygonaceae | Eukaryota | TM-MC* | |||
NPO28024 | Rheum palmatum | Species | Polygonaceae | Eukaryota | TM-MC* | |||
NPO7632 | Rheum tanguticum | Species | Polygonaceae | Eukaryota | TM-MC* | |||
NPO28159 | Rubia akane | Species | Rubiaceae | Eukaryota | TM-MC* | |||
NPO26542 | Rubia cordifolia | Species | Rubiaceae | Eukaryota | TM-MC* | |||
NPO14602 | Vitex negundo | Species | Lamiaceae | Eukaryota | TM-MC* | |||
NPO20064 | Litsea konishii | Species | Lauraceae | Eukaryota | UNPD* | |||
NPO11391 | Polygonum cuspidatum | Species | Polygonaceae | Eukaryota | Roots |
PMID[11459643] |
||
NPO30900 | Morinda parvifolia | Species | Rubiaceae | Eukaryota |
PMID[7097296] |
|||
NPO4323 | Morinda citrifolia | Species | Rubiaceae | Eukaryota | roots |
PMID[18076142] |
||
NPO8020 | Lychnophora columnaris | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO19956 | Pulveroboletus retipes | Species | Boletaceae | Eukaryota | UNPD* | |||
NPO21199 | Alangium platanifolium | Species | Cornaceae | Eukaryota | UNPD* | |||
NPO15980 | Croton penduliflorus | Species | Euphorbiaceae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT138 | Organism | Brugia malayi | Brugia malayi | Mortality | = | 5 | % | 15828820 |
NPT2 | Others | Unspecified | Mortality | = | 3 | % | 15828820 | |
NPT4244 | Individual Protein | RmtA | Emericella nidulans | IC50 | = | 1220000 | nM | 17323938 |
NPT4245 | Individual Protein | Protein-arginine N-methyltransferase 1 | Homo sapiens | IC50 | = | 1160000 | nM | 17323938 |
NPT2 | Others | Unspecified | Activity | = | 0.012 | nM | 18076142 | |
NPT2 | Others | Unspecified | Ratio | = | 5.1 | 18076142 | ||
NPT2 | Others | Unspecified | Activity | > | 0.25 | ug/ml | 2213033 | |
NPT2 | Others | Unspecified | Activity | = | 60 | % | 7097296 | |
NPT2 | Others | Unspecified | IC50 | = | 63900 | nM | 7494143 | |
NPT2 | Others | Unspecified | IC50 | = | 49500 | nM | 7494143 | |
NPT80 | Cell Line | Raji | Homo sapiens | Activity | > | 80 | % | 2558164 |
NPT80 | Cell Line | Raji | Homo sapiens | Activity | = | 60 | % | 2558164 |
NPT2 | Others | Unspecified | Inhibition | = | 100 | % | 2558164 | |
NPT2 | Others | Unspecified | Inhibition | = | 92.4 | % | 2558164 | |
NPT2 | Others | Unspecified | Inhibition | = | 71.4 | % | 2558164 | |
NPT2 | Others | Unspecified | Activity | = | 717 | % | 20005021 | |
NPT35 | Others | n.a. | Activity | = | 246 | % | 20005021 | |
NPT2 | Others | Unspecified | Activity | = | 40 | uL | 20005021 | |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 316227.8 | nM | PubChem BioAssay data set |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT149 | Individual Protein | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT149 | Individual Protein | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 14125.4 | nM | PubChem BioAssay data set |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 28183.8 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 19952.6 | nM | PubChem BioAssay data set | |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT93 | Individual Protein | Survival motor neuron protein | Homo sapiens | Potency | = | 22387.2 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 8912.5 | nM | PubChem BioAssay data set |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 18869.9 | nM | PubChem BioAssay data set |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT583 | Individual Protein | Inositol monophosphatase 1 | Rattus norvegicus | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 125892.5 | nM | PubChem BioAssay data set |
NPT792 | Individual Protein | Arachidonate 15-lipoxygenase | Homo sapiens | Potency | = | 10000 | nM | PubChem BioAssay data set |
NPT792 | Individual Protein | Arachidonate 15-lipoxygenase | Homo sapiens | Potency | = | 5011.9 | nM | PubChem BioAssay data set |
NPT1119 | Individual Protein | Arachidonate 12-lipoxygenase | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | Potency | = | 10000 | nM | PubChem BioAssay data set |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT151 | Individual Protein | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Homo sapiens | Potency | = | 28183.8 | nM | PubChem BioAssay data set |
NPT151 | Individual Protein | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Homo sapiens | Potency | = | 35481.3 | nM | PubChem BioAssay data set |
NPT583 | Individual Protein | Inositol monophosphatase 1 | Rattus norvegicus | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 177827.9 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 14125.4 | nM | PubChem BioAssay data set | |
NPT532 | Individual Protein | Lysine-specific demethylase 4A | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT1005 | Individual Protein | Tumor susceptibility gene 101 protein | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT443 | Individual Protein | Histone acetyltransferase GCN5 | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT1139 | Individual Protein | Arachidonate 15-lipoxygenase, type II | Homo sapiens | Potency | 15848.9 | nM | PubChem BioAssay data set | |
NPT533 | Protein-Protein Interaction | Runt-related transcription factor 1/Core-binding factor subunit beta | Homo sapiens | Potency | 8912.5 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 141253.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | > | 52000 | nM | PubChem BioAssay data set | |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 7079.5 | nM | PubChem BioAssay data set | |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 7943.3 | nM | PubChem BioAssay data set | |
NPT65 | Cell Line | HepG2 | Homo sapiens | Potency | 10000 | nM | PubChem BioAssay data set | |
NPT9 | Individual Protein | DNA polymerase eta | Homo sapiens | Potency | 56234.1 | nM | PubChem BioAssay data set | |
NPT84 | Individual Protein | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Rattus norvegicus | AC50 | = | 4543 | nM | PubChem BioAssay data set |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | 19952.6 | nM | PubChem BioAssay data set | |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | 12589.3 | nM | PubChem BioAssay data set | |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 63095.7 | nM | PubChem BioAssay data set | |
NPT901 | Individual Protein | UDP-glucuronosyltransferase 1-1 | Homo sapiens | Activity | = | 120 | pm/min/mg | 10836148 |
NPT901 | Individual Protein | UDP-glucuronosyltransferase 1-1 | Homo sapiens | Activity | = | 160 | pm/min/mg | 10836148 |
NPT699 | Individual Protein | UDP-glucuronosyltransferase 1-10 | Homo sapiens | Activity | = | 205 | pm/min/mg | 10836148 |
NPT694 | Individual Protein | UDP-glucuronosyltransferase 1-3 | Homo sapiens | Activity | = | 1072 | pm/min/mg | 10836148 |
NPT902 | Individual Protein | UDP-glucuronosyltransferase 1A4 | Homo sapiens | Activity | = | 0 | pm/min/mg | 10836148 |
NPT702 | Individual Protein | UDP-glucuronosyltransferase 1-6 | Homo sapiens | Activity | = | 0 | pm/min/mg | 10836148 |
NPT695 | Individual Protein | UDP-glucuronosyltransferase 1-8 | Homo sapiens | Activity | = | 843 | pm/min/mg | 10836148 |
NPT695 | Individual Protein | UDP-glucuronosyltransferase 1-8 | Homo sapiens | Activity | = | 1500 | pm/min/mg | 10836148 |
NPT703 | Individual Protein | UDP-glucuronosyltransferase 1-9 | Homo sapiens | Activity | = | 1900 | pm/min/mg | 10836148 |
NPT704 | Individual Protein | UDP-glucuronosyltransferase 2B15 | Homo sapiens | Activity | = | 11 | pm/min/mg | 10836148 |
NPT901 | Individual Protein | UDP-glucuronosyltransferase 1-1 | Homo sapiens | Activity | = | 0 | pm/min/mg | 10836148 |
NPT703 | Individual Protein | UDP-glucuronosyltransferase 1-9 | Homo sapiens | Activity | = | 0 | pm/min/mg | 10836148 |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 42266.86 | nM | PubChem BioAssay data set | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 34753.62 | nM | PubChem BioAssay data set | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 41591.06 | nM | PubChem BioAssay data set | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 38636.7 | nM | PubChem BioAssay data set | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 36643.76 | nM | PubChem BioAssay data set | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 42559.84 | nM | PubChem BioAssay data set | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 36057.86 | nM | PubChem BioAssay data set | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 39536.66 | nM | PubChem BioAssay data set | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 32885.16 | nM | PubChem BioAssay data set | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 32359.37 | nM | PubChem BioAssay data set | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 31332.86 | nM | PubChem BioAssay data set | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 38636.7 | nM | PubChem BioAssay data set | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 61235.04 | nM | PubChem BioAssay data set | |
NPT572 | Cell Line | DMS-273 | Homo sapiens | GI50 | 35892.19 | nM | PubChem BioAssay data set | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 34833.73 | nM | PubChem BioAssay data set | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT573 | Cell Line | M19-MEL | Homo sapiens | GI50 | 72443.6 | nM | PubChem BioAssay data set | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 37931.5 | nM | PubChem BioAssay data set | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 57809.6 | nM | PubChem BioAssay data set | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 39445.73 | nM | PubChem BioAssay data set | |
NPT574 | Cell Line | XF498 | Homo sapiens | GI50 | 39084.09 | nM | PubChem BioAssay data set | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 77624.71 | nM | PubChem BioAssay data set | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 49888.45 | nM | PubChem BioAssay data set | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 36475.39 | nM | PubChem BioAssay data set | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 32062.69 | nM | PubChem BioAssay data set | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 37844.26 | nM | PubChem BioAssay data set | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 42953.64 | nM | PubChem BioAssay data set | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 33113.11 | nM | PubChem BioAssay data set | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 28183.83 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 32433.96 | nM | PubChem BioAssay data set | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 37068.07 | nM | PubChem BioAssay data set | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 26915.35 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 31988.95 | nM | PubChem BioAssay data set | |
NPT731 | Cell Line | LXFL 529 | Homo sapiens | GI50 | 43151.91 | nM | PubChem BioAssay data set | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 38904.51 | nM | PubChem BioAssay data set | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 25409.73 | nM | PubChem BioAssay data set | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 39536.66 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 16.1 | nM | PubChem BioAssay data set | ||
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 35645.11 | nM | PubChem BioAssay data set | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 57279.6 | nM | PubChem BioAssay data set | |
NPT484 | Individual Protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | 25574.8 | nM | PubChem BioAssay data set | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 62950.62 | nM | PubChem BioAssay data set | |
NPT534 | Individual Protein | Phosphoglycerate kinase, glycosomal | Trypanosoma brucei brucei | Potency | 25118.9 | nM | PubChem BioAssay data set | |
NPT578 | Cell Line | SNB-78 | Homo sapiens | GI50 | 76032.63 | nM | PubChem BioAssay data set | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 71121.35 | nM | PubChem BioAssay data set | |
NPT579 | Cell Line | DLD-1 | Homo sapiens | GI50 | 43351.09 | nM | PubChem BioAssay data set | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 36559.48 | nM | PubChem BioAssay data set | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 35974.93 | nM | PubChem BioAssay data set | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 94841.85 | nM | PubChem BioAssay data set | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 40831.94 | nM | PubChem BioAssay data set | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 34514.37 | nM | PubChem BioAssay data set | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 3662.6 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 28183.8 | nM | PubChem BioAssay data set | ||
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 22387.2 | nM | PubChem BioAssay data set | |
NPT821 | Individual Protein | Werner syndrome ATP-dependent helicase | Homo sapiens | Potency | 44668.4 | nM | PubChem BioAssay data set | |
NPT755 | Individual Protein | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT159 | Individual Protein | Aberrant vpr protein | Human immunodeficiency virus 1 | Potency | 12589.3 | nM | PubChem BioAssay data set | |
NPT1005 | Individual Protein | Tumor susceptibility gene 101 protein | Homo sapiens | Potency | 32609 | nM | PubChem BioAssay data set | |
NPT980 | Individual Protein | Apoptosis regulator Bcl-2 | Homo sapiens | Ki | = | 1150 | nM | 23167494 |
NPT57 | Individual Protein | Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens | Ki | = | 1620 | nM | 23167494 |
NPT160 | Individual Protein | TAR DNA-binding protein 43 | Homo sapiens | Potency | 39810.7 | nM | PubChem BioAssay data set | |
NPT1854 | Individual Protein | Phosphoglycerate kinase | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | Potency | 20574.9 | nM | PubChem BioAssay data set | |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 84.81 | % | 23571415 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 93.11 | % | 23571415 |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 11883.2 | nM | PubChem BioAssay data set | ||
NPT9 | Individual Protein | DNA polymerase eta | Homo sapiens | Potency | 75686.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 26832.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 9439.2 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 4216 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 19692.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 29849.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 7497.2 | nM | PubChem BioAssay data set | ||
NPT831 | Individual Protein | Serine/threonine-protein kinase PLK1 | Homo sapiens | Potency | 23778.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 7497.8 | nM | PubChem BioAssay data set | ||
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT11 | Individual Protein | Guanine nucleotide-binding protein G(s), subunit alpha | Homo sapiens | Potency | 39810.7 | nM | PubChem BioAssay data set | |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 7568.6 | nM | PubChem BioAssay data set | |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 84367.9 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | IC50 | > | 50000 | nM | 24953029 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | IC50 | = | 39350 | nM | 24953029 |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | IC50 | > | 50000 | nM | 24953029 |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | > | 50000 | nM | 24953029 |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | = | 15650 | nM | 24953029 |
NPT3887 | Cell Line | CNE | Homo sapiens | IC50 | > | 100000 | nM | 24953029 |
NPT165 | Cell Line | HeLa | Homo sapiens | IC50 | > | 100000 | nM | 24953029 |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | > | 50000 | nM | 24953029 |
NPT737 | Cell Line | HUVEC | Homo sapiens | IC50 | > | 50000 | nM | 24953029 |
NPT2 | Others | Unspecified | AC50 | 7943.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 33491.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 8912.5 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC294226 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.969 | High Similarity | NPC258502 |
0.9618 | High Similarity | NPC61398 |
0.9618 | High Similarity | NPC416 |
0.9603 | High Similarity | NPC234175 |
0.9542 | High Similarity | NPC147418 |
0.9474 | High Similarity | NPC203063 |
0.9453 | High Similarity | NPC117609 |
0.9265 | High Similarity | NPC238629 |
0.9206 | High Similarity | NPC375356 |
0.913 | High Similarity | NPC160777 |
0.913 | High Similarity | NPC73416 |
0.9127 | High Similarity | NPC300274 |
0.9127 | High Similarity | NPC91478 |
0.9098 | High Similarity | NPC72918 |
0.9091 | High Similarity | NPC52407 |
0.9077 | High Similarity | NPC99731 |
0.9062 | High Similarity | NPC103540 |
0.9048 | High Similarity | NPC120545 |
0.9023 | High Similarity | NPC44437 |
0.8992 | High Similarity | NPC96915 |
0.8923 | High Similarity | NPC473787 |
0.8881 | High Similarity | NPC50924 |
0.8872 | High Similarity | NPC135801 |
0.8864 | High Similarity | NPC136588 |
0.8864 | High Similarity | NPC199253 |
0.8855 | High Similarity | NPC282923 |
0.8837 | High Similarity | NPC142956 |
0.8824 | High Similarity | NPC53414 |
0.8824 | High Similarity | NPC290030 |
0.8824 | High Similarity | NPC53206 |
0.8815 | High Similarity | NPC153088 |
0.8815 | High Similarity | NPC80035 |
0.8806 | High Similarity | NPC225051 |
0.8806 | High Similarity | NPC111845 |
0.8803 | High Similarity | NPC471907 |
0.8797 | High Similarity | NPC93015 |
0.8797 | High Similarity | NPC469526 |
0.8797 | High Similarity | NPC244699 |
0.8797 | High Similarity | NPC34070 |
0.8759 | High Similarity | NPC4214 |
0.8759 | High Similarity | NPC13715 |
0.875 | High Similarity | NPC118427 |
0.875 | High Similarity | NPC7464 |
0.875 | High Similarity | NPC302783 |
0.875 | High Similarity | NPC473201 |
0.875 | High Similarity | NPC254847 |
0.8731 | High Similarity | NPC70622 |
0.8722 | High Similarity | NPC233056 |
0.8722 | High Similarity | NPC31799 |
0.8722 | High Similarity | NPC26697 |
0.8712 | High Similarity | NPC48248 |
0.8705 | High Similarity | NPC84273 |
0.8702 | High Similarity | NPC3224 |
0.8696 | High Similarity | NPC242994 |
0.8696 | High Similarity | NPC138099 |
0.8696 | High Similarity | NPC472903 |
0.869 | High Similarity | NPC312338 |
0.869 | High Similarity | NPC164912 |
0.869 | High Similarity | NPC149889 |
0.8686 | High Similarity | NPC471905 |
0.8686 | High Similarity | NPC264022 |
0.8676 | High Similarity | NPC283088 |
0.8667 | High Similarity | NPC138472 |
0.8667 | High Similarity | NPC53896 |
0.8657 | High Similarity | NPC205992 |
0.8652 | High Similarity | NPC79627 |
0.8647 | High Similarity | NPC34414 |
0.8647 | High Similarity | NPC146647 |
0.8636 | High Similarity | NPC324209 |
0.8633 | High Similarity | NPC181560 |
0.8633 | High Similarity | NPC169452 |
0.8623 | High Similarity | NPC289358 |
0.8623 | High Similarity | NPC28592 |
0.8623 | High Similarity | NPC469857 |
0.8623 | High Similarity | NPC23667 |
0.8623 | High Similarity | NPC206207 |
0.8623 | High Similarity | NPC114333 |
0.8623 | High Similarity | NPC149773 |
0.8623 | High Similarity | NPC473479 |
0.8623 | High Similarity | NPC157284 |
0.8623 | High Similarity | NPC91887 |
0.8623 | High Similarity | NPC473779 |
0.8623 | High Similarity | NPC165191 |
0.8623 | High Similarity | NPC46242 |
0.8623 | High Similarity | NPC297797 |
0.8623 | High Similarity | NPC42384 |
0.8623 | High Similarity | NPC5014 |
0.8623 | High Similarity | NPC477849 |
0.8623 | High Similarity | NPC50615 |
0.8623 | High Similarity | NPC245760 |
0.8623 | High Similarity | NPC51531 |
0.8621 | High Similarity | NPC144283 |
0.8613 | High Similarity | NPC264112 |
0.8613 | High Similarity | NPC324929 |
0.8613 | High Similarity | NPC155211 |
0.8613 | High Similarity | NPC65005 |
0.8613 | High Similarity | NPC194764 |
0.8611 | High Similarity | NPC37220 |
0.8603 | High Similarity | NPC288089 |
0.8594 | High Similarity | NPC206778 |
0.8594 | High Similarity | NPC285829 |
0.8571 | High Similarity | NPC247250 |
0.8571 | High Similarity | NPC767 |
0.8571 | High Similarity | NPC95537 |
0.8571 | High Similarity | NPC472904 |
0.8561 | High Similarity | NPC190457 |
0.8561 | High Similarity | NPC143438 |
0.8561 | High Similarity | NPC294330 |
0.8561 | High Similarity | NPC231774 |
0.8561 | High Similarity | NPC223336 |
0.8552 | High Similarity | NPC280295 |
0.8551 | High Similarity | NPC49911 |
0.8551 | High Similarity | NPC277559 |
0.855 | High Similarity | NPC173978 |
0.855 | High Similarity | NPC310540 |
0.8538 | High Similarity | NPC307174 |
0.8529 | High Similarity | NPC267205 |
0.8529 | High Similarity | NPC4170 |
0.8529 | High Similarity | NPC115458 |
0.8521 | High Similarity | NPC244691 |
0.8511 | High Similarity | NPC193555 |
0.8511 | High Similarity | NPC169214 |
0.8511 | High Similarity | NPC229218 |
0.8511 | High Similarity | NPC141817 |
0.8511 | High Similarity | NPC73061 |
0.8511 | High Similarity | NPC291078 |
0.8511 | High Similarity | NPC192597 |
0.8511 | High Similarity | NPC19631 |
0.8511 | High Similarity | NPC239136 |
0.8511 | High Similarity | NPC176030 |
0.8504 | High Similarity | NPC150919 |
0.8503 | High Similarity | NPC107109 |
0.85 | High Similarity | NPC473527 |
0.85 | High Similarity | NPC471853 |
0.8496 | Intermediate Similarity | NPC107672 |
0.8493 | Intermediate Similarity | NPC35 |
0.8489 | Intermediate Similarity | NPC471974 |
0.8489 | Intermediate Similarity | NPC469680 |
0.8489 | Intermediate Similarity | NPC469681 |
0.8489 | Intermediate Similarity | NPC230811 |
0.8489 | Intermediate Similarity | NPC141368 |
0.8478 | Intermediate Similarity | NPC315275 |
0.8478 | Intermediate Similarity | NPC223836 |
0.8472 | Intermediate Similarity | NPC10842 |
0.8467 | Intermediate Similarity | NPC282780 |
0.8467 | Intermediate Similarity | NPC166480 |
0.8456 | Intermediate Similarity | NPC178976 |
0.8451 | Intermediate Similarity | NPC199936 |
0.8451 | Intermediate Similarity | NPC66593 |
0.8444 | Intermediate Similarity | NPC244441 |
0.8444 | Intermediate Similarity | NPC55949 |
0.844 | Intermediate Similarity | NPC204045 |
0.844 | Intermediate Similarity | NPC305845 |
0.844 | Intermediate Similarity | NPC246638 |
0.844 | Intermediate Similarity | NPC290550 |
0.8433 | Intermediate Similarity | NPC96024 |
0.8429 | Intermediate Similarity | NPC26924 |
0.8425 | Intermediate Similarity | NPC108288 |
0.8421 | Intermediate Similarity | NPC160499 |
0.8421 | Intermediate Similarity | NPC306765 |
0.8421 | Intermediate Similarity | NPC8745 |
0.8397 | Intermediate Similarity | NPC283514 |
0.8394 | Intermediate Similarity | NPC171968 |
0.8394 | Intermediate Similarity | NPC314048 |
0.8392 | Intermediate Similarity | NPC21599 |
0.8392 | Intermediate Similarity | NPC193703 |
0.8389 | Intermediate Similarity | NPC5379 |
0.8389 | Intermediate Similarity | NPC14561 |
0.8389 | Intermediate Similarity | NPC77807 |
0.8385 | Intermediate Similarity | NPC294361 |
0.8385 | Intermediate Similarity | NPC236520 |
0.8382 | Intermediate Similarity | NPC72669 |
0.8382 | Intermediate Similarity | NPC474517 |
0.838 | Intermediate Similarity | NPC135524 |
0.838 | Intermediate Similarity | NPC469855 |
0.838 | Intermediate Similarity | NPC471971 |
0.838 | Intermediate Similarity | NPC30846 |
0.838 | Intermediate Similarity | NPC471972 |
0.838 | Intermediate Similarity | NPC248068 |
0.837 | Intermediate Similarity | NPC276238 |
0.8369 | Intermediate Similarity | NPC315578 |
0.8369 | Intermediate Similarity | NPC476534 |
0.8369 | Intermediate Similarity | NPC96421 |
0.8358 | Intermediate Similarity | NPC69424 |
0.8358 | Intermediate Similarity | NPC176130 |
0.8358 | Intermediate Similarity | NPC78364 |
0.8358 | Intermediate Similarity | NPC84672 |
0.8357 | Intermediate Similarity | NPC175552 |
0.8357 | Intermediate Similarity | NPC123714 |
0.8346 | Intermediate Similarity | NPC10926 |
0.8345 | Intermediate Similarity | NPC141934 |
0.8345 | Intermediate Similarity | NPC193358 |
0.8345 | Intermediate Similarity | NPC272268 |
0.8345 | Intermediate Similarity | NPC191976 |
0.8345 | Intermediate Similarity | NPC476821 |
0.8345 | Intermediate Similarity | NPC474813 |
0.8333 | Intermediate Similarity | NPC470038 |
0.8333 | Intermediate Similarity | NPC478019 |
0.8333 | Intermediate Similarity | NPC37543 |
0.8333 | Intermediate Similarity | NPC199463 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC294226 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9062 | High Similarity | NPD1470 | Approved |
0.8872 | High Similarity | NPD943 | Approved |
0.875 | High Similarity | NPD1509 | Clinical (unspecified phase) |
0.875 | High Similarity | NPD1201 | Approved |
0.8478 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.8425 | Intermediate Similarity | NPD405 | Clinical (unspecified phase) |
0.8207 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.8028 | Intermediate Similarity | NPD5404 | Approved |
0.8028 | Intermediate Similarity | NPD5406 | Approved |
0.8028 | Intermediate Similarity | NPD5408 | Approved |
0.8028 | Intermediate Similarity | NPD5405 | Approved |
0.7891 | Intermediate Similarity | NPD7390 | Discontinued |
0.7891 | Intermediate Similarity | NPD1511 | Approved |
0.7823 | Intermediate Similarity | NPD3300 | Phase 2 |
0.781 | Intermediate Similarity | NPD1164 | Approved |
0.7785 | Intermediate Similarity | NPD1512 | Approved |
0.7771 | Intermediate Similarity | NPD6232 | Discontinued |
0.7736 | Intermediate Similarity | NPD7473 | Discontinued |
0.7662 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7632 | Intermediate Similarity | NPD3226 | Approved |
0.763 | Intermediate Similarity | NPD3019 | Approved |
0.7603 | Intermediate Similarity | NPD2344 | Approved |
0.7603 | Intermediate Similarity | NPD2346 | Discontinued |
0.7597 | Intermediate Similarity | NPD1934 | Approved |
0.7591 | Intermediate Similarity | NPD9269 | Phase 2 |
0.7586 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7568 | Intermediate Similarity | NPD8166 | Discontinued |
0.7548 | Intermediate Similarity | NPD2801 | Approved |
0.7535 | Intermediate Similarity | NPD3764 | Approved |
0.75 | Intermediate Similarity | NPD2932 | Approved |
0.7462 | Intermediate Similarity | NPD3022 | Approved |
0.7462 | Intermediate Similarity | NPD3021 | Approved |
0.7452 | Intermediate Similarity | NPD3882 | Suspended |
0.7448 | Intermediate Similarity | NPD1607 | Approved |
0.7447 | Intermediate Similarity | NPD9494 | Approved |
0.7431 | Intermediate Similarity | NPD1240 | Approved |
0.7426 | Intermediate Similarity | NPD4196 | Clinical (unspecified phase) |
0.7415 | Intermediate Similarity | NPD2935 | Discontinued |
0.74 | Intermediate Similarity | NPD2309 | Approved |
0.7365 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7347 | Intermediate Similarity | NPD3299 | Clinical (unspecified phase) |
0.7347 | Intermediate Similarity | NPD2799 | Discontinued |
0.7325 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7315 | Intermediate Similarity | NPD1549 | Phase 2 |
0.7299 | Intermediate Similarity | NPD9268 | Approved |
0.7294 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7292 | Intermediate Similarity | NPD2313 | Discontinued |
0.726 | Intermediate Similarity | NPD230 | Phase 1 |
0.7256 | Intermediate Similarity | NPD3818 | Discontinued |
0.7254 | Intermediate Similarity | NPD2798 | Approved |
0.7252 | Intermediate Similarity | NPD9266 | Approved |
0.7252 | Intermediate Similarity | NPD74 | Approved |
0.7248 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7248 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7244 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7239 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7239 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7239 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7233 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7215 | Intermediate Similarity | NPD7819 | Suspended |
0.72 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7194 | Intermediate Similarity | NPD3026 | Approved |
0.7194 | Intermediate Similarity | NPD3023 | Approved |
0.7188 | Intermediate Similarity | NPD3749 | Approved |
0.7176 | Intermediate Similarity | NPD2342 | Discontinued |
0.7176 | Intermediate Similarity | NPD9267 | Approved |
0.7176 | Intermediate Similarity | NPD9263 | Approved |
0.7176 | Intermediate Similarity | NPD9264 | Approved |
0.7176 | Intermediate Similarity | NPD9265 | Clinical (unspecified phase) |
0.7174 | Intermediate Similarity | NPD3025 | Approved |
0.7174 | Intermediate Similarity | NPD3024 | Approved |
0.7171 | Intermediate Similarity | NPD6190 | Approved |
0.7163 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD447 | Suspended |
0.7143 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7105 | Intermediate Similarity | NPD7003 | Approved |
0.7105 | Intermediate Similarity | NPD3750 | Approved |
0.708 | Intermediate Similarity | NPD9493 | Approved |
0.707 | Intermediate Similarity | NPD7458 | Discontinued |
0.7063 | Intermediate Similarity | NPD1203 | Approved |
0.7059 | Intermediate Similarity | NPD5951 | Approved |
0.7055 | Intermediate Similarity | NPD6959 | Discontinued |
0.7039 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7021 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7006 | Intermediate Similarity | NPD5844 | Phase 1 |
0.6994 | Remote Similarity | NPD5494 | Approved |
0.6993 | Remote Similarity | NPD1876 | Approved |
0.6993 | Remote Similarity | NPD1283 | Approved |
0.6977 | Remote Similarity | NPD8150 | Discontinued |
0.6975 | Remote Similarity | NPD7075 | Discontinued |
0.6972 | Remote Similarity | NPD3972 | Approved |
0.6972 | Remote Similarity | NPD4878 | Approved |
0.6964 | Remote Similarity | NPD7074 | Phase 3 |
0.6957 | Remote Similarity | NPD8443 | Clinical (unspecified phase) |
0.6957 | Remote Similarity | NPD3817 | Phase 2 |
0.6934 | Remote Similarity | NPD9281 | Approved |
0.6929 | Remote Similarity | NPD1651 | Approved |
0.6923 | Remote Similarity | NPD2534 | Approved |
0.6923 | Remote Similarity | NPD2533 | Approved |
0.6923 | Remote Similarity | NPD2532 | Approved |
0.6914 | Remote Similarity | NPD7879 | Clinical (unspecified phase) |
0.6905 | Remote Similarity | NPD7054 | Approved |
0.6897 | Remote Similarity | NPD258 | Approved |
0.6897 | Remote Similarity | NPD257 | Approved |
0.6894 | Remote Similarity | NPD7096 | Clinical (unspecified phase) |
0.6892 | Remote Similarity | NPD6663 | Approved |
0.6883 | Remote Similarity | NPD4628 | Phase 3 |
0.6875 | Remote Similarity | NPD7411 | Suspended |
0.6871 | Remote Similarity | NPD4381 | Clinical (unspecified phase) |
0.687 | Remote Similarity | NPD9261 | Approved |
0.6864 | Remote Similarity | NPD7472 | Approved |
0.6859 | Remote Similarity | NPD6143 | Clinical (unspecified phase) |
0.6857 | Remote Similarity | NPD9545 | Approved |
0.6855 | Remote Similarity | NPD5808 | Clinical (unspecified phase) |
0.6852 | Remote Similarity | NPD2296 | Approved |
0.6849 | Remote Similarity | NPD5736 | Approved |
0.6842 | Remote Similarity | NPD2796 | Approved |
0.6842 | Remote Similarity | NPD4338 | Clinical (unspecified phase) |
0.6838 | Remote Similarity | NPD1609 | Clinical (unspecified phase) |
0.6824 | Remote Similarity | NPD7993 | Clinical (unspecified phase) |
0.6824 | Remote Similarity | NPD6797 | Phase 2 |
0.6821 | Remote Similarity | NPD8055 | Clinical (unspecified phase) |
0.6818 | Remote Similarity | NPD1237 | Approved |
0.6813 | Remote Similarity | NPD6599 | Discontinued |
0.6802 | Remote Similarity | NPD8312 | Approved |
0.6802 | Remote Similarity | NPD8313 | Approved |
0.6788 | Remote Similarity | NPD7635 | Approved |
0.6784 | Remote Similarity | NPD7251 | Discontinued |
0.6784 | Remote Similarity | NPD5029 | Approved |
0.6784 | Remote Similarity | NPD5031 | Approved |
0.6784 | Remote Similarity | NPD5027 | Approved |
0.6783 | Remote Similarity | NPD3092 | Approved |
0.6783 | Remote Similarity | NPD1281 | Approved |
0.6776 | Remote Similarity | NPD3748 | Approved |
0.6772 | Remote Similarity | NPD6273 | Approved |
0.6769 | Remote Similarity | NPD3020 | Approved |
0.6766 | Remote Similarity | NPD3926 | Phase 2 |
0.6761 | Remote Similarity | NPD7163 | Clinical (unspecified phase) |
0.6761 | Remote Similarity | NPD2286 | Discontinued |
0.6752 | Remote Similarity | NPD6799 | Approved |
0.675 | Remote Similarity | NPD3455 | Phase 2 |
0.6746 | Remote Similarity | NPD3751 | Discontinued |
0.6744 | Remote Similarity | NPD288 | Approved |
0.6744 | Remote Similarity | NPD5026 | Approved |
0.6744 | Remote Similarity | NPD5034 | Approved |
0.6744 | Remote Similarity | NPD4955 | Approved |
0.6744 | Remote Similarity | NPD36 | Approved |
0.6744 | Remote Similarity | NPD5028 | Approved |
0.6744 | Remote Similarity | NPD4954 | Approved |
0.6742 | Remote Similarity | NPD6534 | Approved |
0.6742 | Remote Similarity | NPD6535 | Approved |
0.6738 | Remote Similarity | NPD3091 | Approved |
0.6736 | Remote Similarity | NPD9717 | Approved |
0.6735 | Remote Similarity | NPD9569 | Approved |
0.6732 | Remote Similarity | NPD1551 | Phase 2 |
0.673 | Remote Similarity | NPD6980 | Clinical (unspecified phase) |
0.6728 | Remote Similarity | NPD6801 | Discontinued |
0.6727 | Remote Similarity | NPD6234 | Discontinued |
0.6726 | Remote Similarity | NPD1220 | Phase 1 |
0.6726 | Remote Similarity | NPD7852 | Clinical (unspecified phase) |
0.6712 | Remote Similarity | NPD3094 | Phase 2 |
0.6711 | Remote Similarity | NPD411 | Approved |
0.671 | Remote Similarity | NPD2800 | Approved |
0.6707 | Remote Similarity | NPD7768 | Phase 2 |
0.6706 | Remote Similarity | NPD1221 | Approved |
0.6705 | Remote Similarity | NPD3534 | Clinical (unspecified phase) |
0.669 | Remote Similarity | NPD1755 | Approved |
0.6689 | Remote Similarity | NPD1529 | Clinical (unspecified phase) |
0.6689 | Remote Similarity | NPD1933 | Approved |
0.6686 | Remote Similarity | NPD5030 | Phase 2 |
0.6685 | Remote Similarity | NPD6212 | Phase 3 |
0.6685 | Remote Similarity | NPD6214 | Clinical (unspecified phase) |
0.6685 | Remote Similarity | NPD6213 | Phase 3 |
0.6667 | Remote Similarity | NPD1878 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD2859 | Approved |
0.6667 | Remote Similarity | NPD2860 | Approved |
0.6667 | Remote Similarity | NPD844 | Approved |
0.6667 | Remote Similarity | NPD5536 | Phase 2 |
0.6667 | Remote Similarity | NPD4308 | Phase 3 |
0.6667 | Remote Similarity | NPD1932 | Approved |
0.6648 | Remote Similarity | NPD6780 | Approved |
0.6648 | Remote Similarity | NPD6776 | Approved |
0.6648 | Remote Similarity | NPD7501 | Clinical (unspecified phase) |
0.6648 | Remote Similarity | NPD6782 | Approved |
0.6648 | Remote Similarity | NPD6777 | Approved |
0.6648 | Remote Similarity | NPD6778 | Approved |
0.6648 | Remote Similarity | NPD6781 | Approved |
0.6648 | Remote Similarity | NPD6779 | Approved |
0.6647 | Remote Similarity | NPD7808 | Phase 3 |
0.6647 | Remote Similarity | NPD1247 | Approved |
0.6646 | Remote Similarity | NPD5978 | Approved |
0.6646 | Remote Similarity | NPD5977 | Approved |
0.6646 | Remote Similarity | NPD8438 | Clinical (unspecified phase) |
0.6644 | Remote Similarity | NPD5952 | Clinical (unspecified phase) |
0.6643 | Remote Similarity | NPD4059 | Approved |
0.6643 | Remote Similarity | NPD4626 | Approved |
0.663 | Remote Similarity | NPD7700 | Phase 2 |
0.663 | Remote Similarity | NPD7699 | Phase 2 |
0.6627 | Remote Similarity | NPD919 | Approved |
PubChem CID   | 6293 |
ChEMBL   | CHEMBL55814 |
ZINC   |
Molecular Weight:   | 240.04 |
ALogP:   | -1.4482 |
MLogP:   | 2.56 |
XLogP:   | 2.155 |
# Rotatable Bonds:   | 2 |
Polar Surface Area:   | 74.6 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 2 |
# Rings:   | 3 |
# Heavy Atoms:   | 18 |